AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
EPIRUBICINE
18 registrations across 3 African markets— 4 active
Markets with EPIRUBICINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| PURIDOX 50MG POUDRE LYOPHILISEE POUR SOLUTION INJECTABLE EN IV BOITE DE 1 | 🇨🇮Côte d'Ivoire | VS INTERNATIONAL SA | expired | Jan 2023 |
| EPIRUBICIN HYDROCHLORIDE ACCORD Solution injectable pour perfusion / 10mg/5ml | 🇹🇳Tunisia | ACCORD HEALTHCARE LTD | expired | Jul 2019 |
| EPIRUBICIN HYDROCHLORIDE ACCORD Solution injectable pour perfusion / 50mg/25ml | 🇹🇳Tunisia | ACCORD HEALTHCARE LTD | expired | Jul 2019 |
| EPIRUBICINE VIATRIS Solution injectable pour perfusion / 2 mg/ml | 🇹🇳Tunisia | VIATRIS SANTE | expired | Jan 2018 |
| EPIRUBICINE VIATRIS Solution injectable pour perfusion / 2 mg/ml (10mg/5ml) | 🇹🇳Tunisia | VIATRIS SANTE | expired | Jan 2018 |
| EPIRUBICINE VIATRIS Solution injectable pour perfusion / 2 mg/ml | 🇹🇳Tunisia | VIATRIS SANTE | expired | Jan 2018 |
| CYTOBICINE Solution injectable pour perfusion / 10 mg/5 ml | 🇹🇳Tunisia | CYTOPHARMA | expired | Jan 2017 |
| CYTOBICINE Solution injectable pour perfusion / 50 mg/25 ml | 🇹🇳Tunisia | CYTOPHARMA | expired | Jan 2017 |
| EPIRUBICIN THYMOORGAN Solution injectable pour perfusion / 10 mg/5 ml | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Jul 2016 |
| EPIRUBICIN THYMOORGAN Solution injectable pour perfusion / 50 mg/25 ml | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Jul 2016 |
| EPIRUBICIN THYMOORGAN Solution injectable pour perfusion / 200 mg/100 ml | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Jul 2016 |
| EPIRUBICIN KABI Solution injectable pour perfusion / 2mg/ml(50mg) | 🇹🇳Tunisia | FRESENIUS KABI ONCOLOGY PLC | expired | Jan 2014 |
| EPIRUBICINE EBEWE Solution injectable pour perfusion / 2 mg/ml | 🇹🇳Tunisia | EBEWE Pharma | expired | Dec 2005 |
| EPIRUBICINE EBEWE Solution injectable pour perfusion / 2 mg/ml | 🇹🇳Tunisia | EBEWE Pharma | expired | Dec 2005 |
| EPIRUBICINE MYLAN 2 MG/ML SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| FARMORUBICINE POUDRE POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| EPIRUBICINE MYLAN 2 MG/ML SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| FARMORUBICINE POUDRE POUR PERFUSION | 🇲🇦Morocco | — | active | — |
EPIRUBICINE in Africa — Regulatory Overview
EPIRUBICINE is registered across 3 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.
Of the 18 registrations, 4 (22%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.